March 16 (Reuters) - Latvian government health agencies on
Tuesday announced a "temporary suspension" of up to two weeks of
the use of AstraZeneca's COVID-19 vaccine in the
country.
The move is "an additional precaution" while the vaccine is
scrutinized, and no problems have been linked to its use in
Latvia, the agencies said in a statement.
"The decision is based on reports from individual European
Union countries of thromboembolism and similar cases observed at
various times after receiving the vaccine," they said. "To date,
there is no data on the causal link between vaccination and
serious health problems."
Germany, France and Italy said on Monday they would stop
administering the AstraZeneca COVID-19 vaccine after several
countries reported possible serious side-effects, while the
World Health Organization said there was no proven link.
(Reporting By Andrius Sytas; Editing by Catherine Evans)
Astrazeneca (AZN)
